As the 70-year-old CEO of EDP Biotech Corp. in Knoxville, Tom Boyd (at left, in shirt from another venture) must be an interesting guy, and his firm probably deserves the sudden buzz they're getting, as a result of their announcement Friday, which read in part, saying the company has introduced a "revolutionary new technology for a simple blood test to detect early-stage colon cancer. Following the success of its pre-clinical trials for the ColoMarker™ assay, EDP has filed a patent on the biomarker, CA11-19, and all aspects of its use. Via an inexpensive blood test, ColoMarker™ will detect colon cancer in its earliest, most curable stages."
Sunday, December 20, 2009
Cancer-detection breakthrough
As the 70-year-old CEO of EDP Biotech Corp. in Knoxville, Tom Boyd (at left, in shirt from another venture) must be an interesting guy, and his firm probably deserves the sudden buzz they're getting, as a result of their announcement Friday, which read in part, saying the company has introduced a "revolutionary new technology for a simple blood test to detect early-stage colon cancer. Following the success of its pre-clinical trials for the ColoMarker™ assay, EDP has filed a patent on the biomarker, CA11-19, and all aspects of its use. Via an inexpensive blood test, ColoMarker™ will detect colon cancer in its earliest, most curable stages."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment